Summary
This 8-K filing by Amgen Inc. (AMGN) on October 27, 2014, primarily serves to report the company's unaudited financial results for the three and nine months ended September 30, 2014. The filing indicates that a press release detailing these results, along with the company's financial position as of September 30, 2014, was issued on the same day. Investors should note that the accompanying press release includes non-GAAP financial measures, such as adjusted earnings per share and free cash flow. Amgen's management provides explanations within the press release for why these non-GAAP measures are considered useful for investors and how they are used internally. Reconciliations between these non-GAAP figures and their most comparable GAAP counterparts are also provided in the press release.
Key Highlights
- 1Amgen announced its unaudited financial results for the third quarter and the first nine months of 2014.
- 2The report includes the company's unaudited financial position as of September 30, 2014.
- 3A press release detailing the financial results was issued on October 27, 2014.
- 4The press release contains non-U.S. Generally Accepted Accounting Principles (GAAP) financial measures.
- 5Key non-GAAP measures mentioned include adjusted earnings per share, free cash flow, adjusted operating income, and adjusted tax rate.
- 6Amgen's management explains the rationale for presenting non-GAAP measures and their utility to investors.
- 7Reconciliations between non-GAAP and GAAP financial measures are included in the press release.